Mapping transcription factor (TF) binding sites across the genome is key to understanding how cells control gene expression, yet pinpointing their footprints across the genome—especially in single ...
Effect of fusion of radiomic, pathomic, and clinical biomarkers on multi-scale tumor biology and OS stratification in HNSCC receiving standard of care (SOC). Phase 2 trial of ozuriftamab vedotin ...
"Identifying patients with baseline characteristics that indicate higher risk of transformation should lead to closer monitoring of these patients and early repeat biopsy…The current findings ...
Anti-LAT1 monoclonal antibodies significantly inhibited in vitro cell proliferation and in vivo tumor growth of naLAT1/3T3 cells in nude mice, demonstrating LAT1 to be a promising anti-cancer target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback